MMP1 and breast cancer: Moreover, inhibition of the NF-κB pathway by PDTC in MMP1-overexpressing BC cells weakened cell migration, invasion, and proliferation, as evidenced by transwell assays (Fig. 5c, d) and wound scratch assays (Fig. 5e, f).